Despite Nuclear Medicine’s role in personalized medicine and the potential it offers with its diagnostic and therapeutic opportunities, it remains a complex discipline to be explained to all stakeholders. Very few people are aware of all the workings of this technique. Moreover, even less know about the high potential of radiolabeled molecules in therapeutic applications, which may change the way of treating cancer patients in the very near future.

The Nuclear Medicine Europe Communications Working Group’s mission is to communicate most efficiently all relevant information regarding Nuclear Medicine and Molecular Imaging industry to all stakeholders and influencers, such as the European Union Parliament, the European Union Commission, EU governments, national and international pharmaceutical agencies, physicians, patient groups and the public in general. Nuclear Medicine Europe, through this Working Group, will also provide accurate scientific information to journalists who will relay it to the press.

The Working Group will be responsible for optimizing messages and selecting the right media for each occasion. The context of such communications will come from the different Nuclear Medicine Europe Working Groups, external consultants, and partners. The Group will also participate in the organization of the annual Nuclear Medicine Europe Symposium.

The Group will support educational activities and may create together with assigned experts teaching materials for the Nuclear Medicine Europe related communities: patients, medical/nuclear physicians and decision-makers/influencers.